Target, Home Depot,...
Health Care: Drugs
Inovio Pharmaceuticals Inc. (INO: AMEX)
$0.67 0.01 | 1.20%
05/17/13 - 03:59 PM ET
Company Cash Flow
| Dec 2012 | Dec 2011 | Dec 2010 | Dec 2009 | |
| Cash Flow From Operating Activities | ||||
|---|---|---|---|---|
| Net Income (Loss) | -19.71M | -15.30M | -17.64M | -24.46M |
| Operating Gains/Losses | -2.78M | 1.81M | 991.10K | 9.17M |
| Extraordinary Gains / Losses | 0.00 | 0.00 | 0.00 | 0.00 |
| (Increase) Decrease In Receivables | -360.35K | -401.28K | 213.02K | 1.39M |
| (Increase) Decrease in Inventories | 0.00 | 0.00 | 0.00 | 0.00 |
| (Increase) Decrease In Other Current Assets | 0.00 | -100.06K | 0.00 | 0.00 |
| (Decrease) Increase In Payables | 166.93K | 128.77K | 1.08M | 428.35K |
| (Decrease) Increase In Other Current Liabilities | 0.00 | 0.00 | 0.00 | 0.00 |
| (Increase) Decrease In Other Working Capital | -898.94K | -644.32K | 2.87M | -5.74M |
| Other Non-Cash Items | -653.95K | -7.00M | -1.05M | 3.20M |
| Net Cash From Continuing Operations | -22.31M | -19.76M | -11.94M | -14.08M |
| Net Cash From Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Provided By Investing Activities | ||||
| Net Cash From Total Operating Activities | -22.31M | -19.76M | -11.94M | -14.08M |
| Sale of Property, Plant & Equipment | 650.00K | 350.00K | 0.00 | 0.00 |
| Cash Used for Investing Activities | ||||
| Sale of Short-Term Investments | 0.00 | 0.00 | 19.71M | 0.00 |
| Purchases of Property, Plant & Equipment | -240.99K | -161.19K | -306.63K | -164.94K |
| Acquisitions | 0.00 | 0.00 | 0.00 | 1.61M |
| Purchases of Short-Term Investments | 0.00 | 0.00 | -8.00M | 0.00 |
| Other Cash from Investing Activities | 0.00 | -18.19M | 32.50K | 0.00 |
| Cash Provided by Financing Activities | ||||
| Net Cash From Investing Activities | 5.28M | -10.90M | 11.44M | 1.45M |
| Issuance of Debt | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Used for Financing Activities | ||||
| Issuance of Capital Stock | 5.33M | 28.01M | 2.48M | 28.77M |
| Repayment of Long-Term Debt | 0.00 | 0.00 | -12.18M | -160.84K |
| Repurchase of Capital Stock | 0.00 | 0.00 | 0.00 | 0.00 |
| Payment of Cash Dividends | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Financing Charges, Net | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Cash From Financing Activities | 5.33M | 28.01M | -9.69M | 28.60M |
| Effect of Exchange Rate Changes | 1.98K | -3.26K | -102.95K | 210.53K |
| Net Change in Cash & Cash Equivalents | -11.70M | -2.65M | -10.30M | 16.18M |
Portfolios with INO
- Portfolio NameUser Type
- ContributorStocks Under-$10 Moving Hig...
- UserCore and Growth Portfolio
- UserWatch
- ContributorStocks Under-$10 Setting Up...
- Uservlady 1
- ContributorBreakout Stocks Of The Week...
- UserSUPRATRADE HOT STOCKS (BUY ...
- UserAjit Kumar Portfolio 2
- Userraju singh Portfolio 1
- Userdragan municipal incorporation
Latest INO Headlines from TheStreet
- Investing Ideas For Flu Season 11.28.12 | 05:11 pm
- 5 Stocks Under $10 Set to Soar 10.18.12 | 12:10 pm
- 5 Stocks Setting Up to Break Out 12.28.11 | 02:12 pm
- Allied Irish Banks, Bell Microproducts: Early Volume Plays 03.29.10 | 07:03 am
- DryShips, Synovus: Late Volume Plays 11.20.09 | 03:11 pm
- Swine Flu Biotech Bubble Primed to Burst 09.10.09 | 11:09 am
- Osiris Stem Cell Drug Fails: BioBuzz 09.08.09 | 08:09 am
- Inovio's CEO Defends Swine Flu Drug (Part 2) 08.07.09 | 02:08 pm
- Inovio Digs for Truffles With Swine-Flu Drug (Part 1) 08.07.09 | 02:08 pm
- Stock Search: Citigroup, Bank of America, Ford 08.03.09 | 12:08 pm
Press Releases for INO
- Inovio Pharmaceuticals Universal H1N1 Influenza Vaccine Achieves Protective Immune Responses Comparable To Conventional Vaccine In Phase I Study - PR Newswire 04.18.13 | 12:04 pm
- Inovio Pharmaceuticals Recognized With "Best Therapeutic Vaccine" And "Best Early Stage Biotech" Awards At World Vaccine Congress 2013 - PR Newswire 04.18.13 | 04:04 am
- Inovio Pharmaceuticals & U.S. Army Receive $3.5 Million Biodefense Grant To Further Develop Mass Vaccination Device - PR Newswire 04.10.13 | 09:04 am
- Inovio Collaborator ChronTech Reports Interim Phase II Clinical Study Results From ChronVac-C Vaccine For Hepatitis C Infection - PR Newswire 04.02.13 | 04:04 am
- Inovio Pharmaceuticals To Present At BioCentury's "Future Leaders In The Biotech Industry" Conference - PR Newswire 03.28.13 | 04:03 am
- Inovio Pharmaceuticals Closes $15.1 Million Offering Of Common Stock And Warrants - PR Newswire 03.12.13 | 04:03 pm
- Inovio Pharmaceuticals Prices $15.1 Million Offering Of Common Stock And Warrants - PR Newswire 03.07.13 | 06:03 am
- Inovio Pharmaceuticals To Present At The Cowen & Company Health Care Conference - PR Newswire 02.27.13 | 04:02 am
- Inovio Pharmaceuticals, Inc. Investor Presentation Now Available For On-demand Viewing At RetailInvestorConferences.com - PR Newswire 02.11.13 | 07:02 am
- Inovio Pharmaceuticals, Inc. To Webcast, Live, At RetailInvestorConferences.com On February 7th - PR Newswire 02.05.13 | 07:02 am
Partner Headlines for INO
- Stock Watch Thursday, 11 April 2013 - Seeking Alpha 04.11.13 | 09:04 am
- This Could Be The Coming Out Year For Inovio Pharmaceuticals - Seeking Alpha 01.22.13 | 09:01 am
- Stock Watch Tuesday, 8 January - Seeking Alpha 01.08.13 | 09:01 am
- Stock Watch Wednesday, 2 January - Seeking Alpha 01.02.13 | 08:01 am
- Stock Watch Tuesday, 18 December - Seeking Alpha 12.18.12 | 08:12 am
- 5 Pharmaceutical Companies With Insider Buying During August 14-16 - Seeking Alpha 08.19.12 | 05:08 am
- Investment Potential In Electroporation Companies - Seeking Alpha 07.17.12 | 09:07 am
- Weekly CFO Buys Highlight: ZBB, INO, LPR, PMC, FGP, PRMW - GuruFocus 06.17.12 | 02:06 pm
- Weekly CFO Buys Highlight: BWEN, EMC, INO, DCTH, ACCO - GuruFocus 06.11.12 | 01:06 pm
- Inovio Pharmaceuticals Synthetic DNA Vaccine Protects Against HIV in Non-Human Primates - Benzinga 07.05.11 | 09:07 am
